CHAD

chondroadherin, the group of Small leucine rich repeat proteoglycans

Basic information

Region (hg38): 17:50464496-50468906

Links

ENSG00000136457NCBI:1101OMIM:602178HGNC:1909Uniprot:O15335AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CHAD gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHAD gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
20
clinvar
3
clinvar
23
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 20 0 5

Variants in CHAD

This is a list of pathogenic ClinVar variants found in the CHAD region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-50465305-C-A not specified Uncertain significance (Nov 10, 2024)3491824
17-50465329-G-A Benign (Jul 15, 2018)779024
17-50465331-G-A Benign (Jul 15, 2018)786655
17-50465347-C-T not specified Uncertain significance (Oct 14, 2023)3143992
17-50465348-G-A not specified Uncertain significance (Feb 23, 2023)2463519
17-50465353-G-T Likely benign (Dec 01, 2024)3770411
17-50465354-C-T not specified Uncertain significance (Aug 27, 2024)3491820
17-50465366-G-A not specified Uncertain significance (Feb 07, 2025)3832699
17-50465708-G-A not specified Uncertain significance (May 22, 2023)2535215
17-50465812-T-A not specified Uncertain significance (Mar 10, 2025)3832704
17-50465849-C-T not specified Uncertain significance (Jul 14, 2024)2378108
17-50465857-G-C not specified Uncertain significance (Sep 02, 2024)3491821
17-50468138-G-A Benign (Jun 27, 2018)778715
17-50468149-T-C not specified Uncertain significance (Feb 04, 2025)3832698
17-50468191-G-A not specified Uncertain significance (May 04, 2023)2525076
17-50468222-C-T not specified Uncertain significance (Jan 24, 2023)2462344
17-50468243-G-C Benign (Jul 15, 2018)727559
17-50468251-G-A not specified Uncertain significance (Sep 24, 2024)3491823
17-50468326-C-T not specified Uncertain significance (Mar 21, 2023)2509568
17-50468342-T-C not specified Uncertain significance (Mar 20, 2023)2527129
17-50468365-A-G not specified Uncertain significance (Jan 08, 2025)3832700
17-50468380-G-A not specified Uncertain significance (Jun 22, 2024)3266769
17-50468454-G-T not specified Uncertain significance (Mar 21, 2023)2509587
17-50468506-T-C not specified Uncertain significance (Jun 28, 2024)3491819
17-50468595-G-A not specified Likely benign (Jan 09, 2025)3832703

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CHADprotein_codingprotein_codingENST00000508540 34471
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.006980.9261257260201257460.0000795
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6752062350.8760.00001582313
Missense in Polyphen94101.670.92454977
Synonymous2.14831120.7430.00000752764
Loss of Function1.58510.50.4754.47e-7128

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003510.000351
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00006180.0000615
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Promotes attachment of chondrocytes, fibroblasts, and osteoblasts. This binding is mediated (at least for chondrocytes and fibroblasts) by the integrin alpha(2)beta(1). May play an important role in the regulation of chondrocyte growth and proliferation (By similarity). {ECO:0000250}.;
Pathway
PI3K-Akt signaling pathway - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway (Consensus)

Recessive Scores

pRec
0.224

Intolerance Scores

loftool
0.201
rvis_EVS
0.33
rvis_percentile_EVS
73.54

Haploinsufficiency Scores

pHI
0.303
hipred
Y
hipred_score
0.507
ghis
0.465

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.251

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Chad
Phenotype
adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; skeleton phenotype;

Gene ontology

Biological process
bone development;negative regulation of bone trabecula formation
Cellular component
extracellular space;extracellular matrix
Molecular function